Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Trauma Acute Care Surg. 2012 Jul;73(1):146-51. doi: 10.1097/TA.0b013e318251f9aa.

    Is futile care in the injured elderly an important target for cost savings?

    Source

    Department of Emergency Medicine, Oregon Health & Science University, Portland, OR, USA. fleischr@ohsu.edu

    Abstract

    BACKGROUND:

    This study proposes a definition of futile care and quantifies its cost in injured elders.

    METHODS:

    This was a retrospective study of Medicare patients with an International Classification of Diseases-9 injury diagnosis admitted to 171 Oregon and Washington facilities from January 1, 2001, through December 31, 2002, who died within 6 months of admission. Futile care was defined as death within 7 days of discharge from a hospitalization of at least 14 days. We compared health care costs in the last 6 months of life with those who did and did not meet our definition of futility. To simulate predicting and preventing futility early in the hospital course, we examined the effect of reducing spending on the futile care cohort to the level of those who survived 7 to 10 days after injury.

    RESULTS:

    There were 6,832 elders who died within 6 months of injury, of whom 230 (3.4%) met our definition of futility. The median cost of care in the last 6 months of life was $33,373 for those not meeting our definition of futility and $87,391 for the futile care group (p < 0.001). The 3.4% receiving futile care incurred 8.9% of total costs. Reducing expenditures in the futile care group to the level of those who died from 7 to 10 days after injury (median, $25,633) would result in an overall cost savings of 6.5%.

    CONCLUSION:

    End-of-life health care costs were significantly higher for those who received futile care. However, even aggressive reductions in futile care would result in small savings overall.

    LEVEL OF EVIDENCE:

    Economic analysis, level III.

    PMID:
    22743384
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3510698
    [Available on 2013/7/1]

      Supplemental Content

      Icon for Lippincott Williams & Wilkins

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk